1

The Commercial Trajectory of Single-Strain vs. Multi-Strain HMO Blends: Analyzing 2026 Formulation Shifts in Premium Pediatric Portfolios (2026–2033)

akshay778
Data Bridge Market Research analyses that the human milk oligosaccharides (HMOs) in infant formula market is expected to reach USD 540.12 billion by 2030, which is USD 115.24 billion in 2022, registering a CAGR of 21.30% during the forecast period of 2023 to 2030. https://www.databridgemarketresearch.com/reports/global-human-milk-oligosaccharides-in-infant-formula-market
Report this page

Comments

    HTML is allowed

Who Upvoted this Story